Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:51:56 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:DBVT from 2023-04-30 to 2024-04-29 - 26 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-25 16:30U:DBVTNews ReleaseCombined General Meeting of May 16, 2024
2024-04-04 16:44U:DBVTNews ReleaseInformation regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
2024-03-08 09:33U:DBVTNews ReleaseDBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
2024-03-07 16:30U:DBVTNews ReleaseDBV Technologies Reports Full Year 2023 Financial Results and Business Update
2024-03-04 16:30U:DBVTNews ReleaseDBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
2024-02-20 16:30U:DBVTNews ReleaseDBV Technologies to Participate in Upcoming AAAAI 2024 Congress
2024-01-16 16:30U:DBVTNews ReleaseHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
2023-12-04 16:30U:DBVTNews ReleaseInformation regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023 ‚  
2023-11-09 16:30U:DBVTNews ReleaseDBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin ¢ „ ¢ Peanut in Toddlers
2023-11-06 16:30U:DBVTNews ReleaseMonthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
2023-11-02 16:30U:DBVTNews ReleaseDBV Technologies to Present New Data at ACAAI 2023
2023-10-31 16:30U:DBVTNews ReleaseDBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
2023-10-27 16:30U:DBVTNews ReleaseDBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
2023-10-16 02:00U:DBVTNews ReleaseDBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
2023-10-05 16:30U:DBVTNews ReleaseMonthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
2023-09-05 16:30U:DBVTNews ReleaseDBV Technologies to Participate in Upcoming Investor Conference
2023-07-31 16:25U:DBVTNews ReleaseDBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
2023-07-25 16:30U:DBVTNews ReleaseDBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
2023-07-19 16:30U:DBVTNews ReleaseMonthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
2023-07-10 16:30U:DBVTNews ReleaseHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
2023-06-16 16:30U:DBVTNews ReleaseMonthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023
2023-06-08 16:30U:DBVTNews ReleaseDBV Technologies to Participate in Upcoming EAACI Congress 2023
2023-06-06 17:00U:DBVTNews ReleaseDBV Technologies to Participate in Upcoming Investor Conference
2023-05-10 17:30U:DBVTNews ReleaseDBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin ¢ „ ¢ Peanut in Toddlers
2023-05-09 16:30U:DBVTNews ReleaseDBV Technologies to Participate in Upcoming Investor Conference
2023-05-04 16:30U:DBVTNews ReleaseDBV Technologies Reports First Quarter 2023 Financial Results